ArticlePDF Available

Rapid Identification of Shiga Toxin–Producing Escherichia coli O Serogroups from Fresh Produce and Raw Milk Enrichment Cultures by Luminex Bead–Based Suspension Array

Authors:

Abstract

The U.S. Food and Drug Administration's Bacteriological Analytical Manual (BAM) Chapter 4a describes a Luminex microbead-based suspension array used to screen colonies for 11 clinically relevant Shiga toxin-producing Escherichia coli (STEC) serogroups: O26, O45, O91, O103, O104, O111, O113, O121, O128, O145, and O157. We evaluated the usefulness of this method to identify STEC-positive enrichment samples before agar plating. Twelve E. coli strains were added to three types of fresh produce (bagged baby spinach, alfalfa sprouts, and cilantro) at levels near the detection limit of the test. A subset of these strains (six O serogroups) was similarly evaluated in raw milk. For comparison, portions of each of the 168 enrichment cultures were analyzed for serogroup by a real-time PCR assay and a Bio-Plex 200 assay with the bead-based suspensions. No false-positive results were obtained. Of the 112 samples with a reported cycle threshold (CT) value, 101 undiluted, diluted, or extracted enrichment cultures also produced ratios above 5.0 in the Bio-Plex assay. When PCR CT values approached or were greater than 35, Bio-Plex detection became less reliable. Using undiluted or extracted enrichment cultures resulted in a significantly larger number of positive results. With the same enrichment material prepared for real-time PCR analysis as described in the BAM Chapter 4a, the STEC microbead-based suspension array can accurately screen food enrichment cultures. © 2016, International Association for Food Protection. All rights reserved.
Journal of Food Protection, Vol. 79, No. 9, 2016, Pages 1623–1629
doi:10.4315/0362-028X.JFP-16-070
Research Note
Rapid Identification of Shiga Toxin–Producing Escherichia coli
O Serogroups from Fresh Produce and Raw Milk Enrichment
Cultures by Luminex Bead–Based Suspension Array
JULIE A. KASE,
1
*ANNA MAOUNOUNEN-LAASRI,
1,2
AND ANDREW LIN
3
1
U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Division of Microbiology, College Park, Maryland 20740;
2
Oak Ridge
Research Institute for Science and Education, Oak Ridge, Tennessee 37830; and
3
U.S. Food and Drug Administration, Office of Regulatory Affairs, San
Francisco Laboratory, Alameda, California 94502, USA
MS 16-070: Received 12 February 2016/Accepted 14 May 2016
ABSTRACT
The U.S. Food and Drug Administration’s Bacteriological Analytical Manual (BAM) Chapter 4a describes a Luminex
microbead–based suspension array used to screen colonies for 11 clinically relevant Shiga toxin–producing Escherichia coli
(STEC) serogroups: O26, O45, O91, O103, O104, O111, O113, O121, O128, O145, and O157. We evaluated the usefulness of
this method to identify STEC-positive enrichment samples before agar plating. Twelve E. coli strains were added to three types of
fresh produce (bagged baby spinach, alfalfa sprouts, and cilantro) at levels near the detection limit of the test. A subset of these
strains (six O serogroups) was similarly evaluated in raw milk. For comparison, portions of each of the 168 enrichment cultures
were analyzed for serogroup by a real-time PCR assay and a Bio-Plex 200 assay with the bead-based suspensions. No false-
positive results were obtained. Of the 112 samples with a reported cycle threshold (C
T
) value, 101 undiluted, diluted, or extracted
enrichment cultures also produced ratios above 5.0 in the Bio-Plex assay. When PCR C
T
values approached or were greater than
35, Bio-Plex detection became less reliable. Using undiluted or extracted enrichment cultures resulted in a significantly larger
number of positive results. With the same enrichment material prepared for real-time PCR analysis as described in the BAM
Chapter 4a, the STEC microbead-based suspension array can accurately screen food enrichment cultures.
Key words: Bio-Plex 200 instrumentation; Food enrichment; Luminex; O serogroup identification; Shiga toxin–producing
Escherichia coli
Shiga toxin–producing Escherichia coli (STEC) strains
are a significant public health concern, causing an estimated
170,000 illnesses in the United States each year (14). Over
100 different E. coli O serogroups are associated with Shiga
toxin production, although not all STEC strains are
pathogenic for humans (1, 3). However, some STEC strains
are as virulent as O157:H7, causing bloody diarrhea, life
threating conditions such as hemorrhagic colitis (HC) and
hemolytic uremic syndrome (HUS), and even death (2, 7,
10). Relatively few cells of these pathogens are needed to
cause disease, and the consumption of contaminated foods
or drinking water or close contact with STEC-infected
animals can be important transmission routes for STEC
infections in humans (4, 5, 15).
Governmental food regulatory agencies struggle with
identifying pathogenic STEC so that contaminated material
can be removed from the food supply and isolates obtained
from clinical, food, and environmental samples can be
matched. Part of the challenge for regulatory agencies is
differentiating between pathogenic STECs and those that do
not have the potential to cause illness. Although certain
virulence factors, such as intimin, have been implicated as
indicators of pathogenic potential (13), certain STEC O
serogroups are associated with clinical disease more often
than other serogroups. For example, particular serogroups
are known to cause HC and HUS (O26, O103, O111, O121,
and O145), and O45 is associated with HC (3, 8); however,
other serogroups (O91, O113, and O128) may cause HC and
HUS but are less commonly isolated (1, 8).Other
serogroups also may emerge as public health concerns, as
occurred in 2011 with the E. coli strain O104:H4. A single
multinational E. coli O104:H4 infection outbreak resulted in
908 cases of HUS and 50 deaths in 16 countries, including
the United States (16).
The current version of the U.S. Food and Drug
Administration (FDA) Bacteriological Analytical Manual
(BAM) (6) contains a culture method for the recovery and
detection of O157:H7 and non-O157 STEC from leafy
produce, which is based on the enrichment of produce rinses
followed by the use of chromogenic and selective or
differential plating agars. Milk and other liquids are first
centrifuged, and then samples are enriched and plated on
those same agars. For detection of Shiga toxin (i.e., coded by
genes stx
1
and stx
2
), a small portion of the enrichment
material or suspect colonies from the plating agars are
* Author for correspondence. Tel: 240-402-2923; Fax: 301-436-
2915; E-mail: julie.kase@fda.hhs.gov.
1623
Downloaded from http://meridian.allenpress.com/jfp/article-pdf/79/9/1623/2322935/0362-028x_jfp-16-070.pdf by guest on 02 January 2023
subjected to a real-time PCR assay. Colonies can be further
evaluated on a Bio-Plex 200 instrument using a Luminex
microsphere–based suspension array that identifies the O
serogroup of pure culture isolates of the 11 most clinically
relevant STEC serogroups: O26, O45, O91, O103, O104,
O111, O113, O121, O128, O145, and O157 (11). This
validated assay replaces the traditional serotyping method of
testing agglutination with O serogroup–specific antisera and
offers many advantages, including better accuracy and
higher throughput. Although this assay has been very
effective for confirming colonies picked from agar plates,
several days may pass until a colony is obtained, costing
valuable time. Use of this assay to screen enrichment
samples, as previous work has demonstrated with bacterial
colonies, would allow early indication of a positive sample
and the particular serogroup involved, which might better
direct the use of particular agars (9, 11). Following the FDA
BAM procedure (Chapter 4a, Section N) (6), we evaluated
the suitability of the Luminex microsphere–based suspen-
sion array for identifying STEC-positive test portions of
enrichment cultures of artificially contaminated fresh
produce (bagged baby spinach, alfalfa sprouts, and cilantro)
and raw cow’s milk.
MATERIALS AND METHODS
Source of fresh produce, raw milk, and inocula. Bagged
baby spinach, packages of alfalfa sprouts, and bunches of cilantro
were purchased from local supermarkets in the Washington, DC
metropolitan area. Raw milk was obtained from cows maintained
at the FDA Center for Veterinary Medicine (courtesy of Dr. Oscar
Chiesa) for research purposes. E. coli strains used as inocula were
O26:H11 (TW02295), O45:NM (TW01589), O91:(TW05662),
O103:H6 (TW04162), O111:NM (TW06315), O113:H21
(TW00125), O121:NM (TW08004), and O145:NM (TW07596)
from the Thomas S. Whittam STEC Center (Michigan State
University, East Lansing); O104:H4 from Lawrence Connolly
(Massachusetts Department of Public Health, Boston); O104:H21
from Dr. Peter Feng (FDA, Silver Spring, MD); and O128
(BM2020) from Dr. Robert Mandrell (U.S. Department of
Agriculture, Agricultural Research Service, Washington, DC).
Preparation of inocula, food inoculation, enrichment
procedure, and real-time PCR screening. Preparation of inocula,
food inoculation, enrichment procedure, and real-time PCR
screening were all completed using food enrichment cultures
produced in a previous study (9). Test portions of approximately
100 g of baby spinach, cilantro, or alfalfa sprouts or 800 ml of raw
milk were inoculated with E. coli strains, placed in a sealable
container, mixed thoroughly by shaking for several minutes or by
inverting the container three to five times (raw milk), held for 48 h
at 48C for aging, and then split into four 25-g test portions by
produce type or four 200-ml test portions (raw milk). Inoculum
levels of approximately 0.05 CFU/g of produce or 0.05 CFU/ml of
milk (or levels that would provide fractionally positive results as
empirically determined) were used. Fractionally positive results are
results where some of the test portions per experiment (ideally
50%) produce positive results and some produce negative results.
Enrichment cultures were grown in 13modified buffered peptone
water with pyruvate under the exact conditions described in the
BAM (6). Uninoculated portions of produce or raw milk were also
processed with the inoculated test portions and enriched, as
described above, as controls for cross-contamination during
processing of the inoculated material. Nucleic acid extraction from
1.0-ml enrichment culture samples was performed using the
DNeasy blood and tissue kit (Qiagen, Valencia, CA) according to
the manufacturer’s instructions for gram-negative bacteria.
Luminex microsphere–based suspension array and oper-
ation of the Bio-Plex 200 instrument. Primers and probes used
and the details of the PCR, bead hybridization, and Bio-Plex
analysis are described elsewhere (11). PCRs were conducted using
a C1000 thermocycler (Bio-Rad, Hercules, CA). The STEC
molecular serotyping protocol is provided in the BAM. Protocol
procedures were followed without deviation as described. The
resulting PCR product for each enrichment sample was run in
triplicate on the Bio-Plex 200 instrument, and mean results are
reported in Table 1. In some cases, PCR products were stored
overnight at 48C.
Statistical analysis. The number of positive Bio-Plex ratios
(Table 1) achieved using diluted, undiluted, and extracted
enrichment material was analyzed with Fisher’s exact test using
GraphPad software (www.graphpad.com). Significance was as-
sessed with a two-tailed Pvalue of less than 0.0001.
RESULTS
Eleven E. coli O serogroups (12 E. coli strains) were
evaluated in food enrichment cultures prepared with three
types of fresh produce: bagged baby spinach, alfalfa sprouts,
and cilantro. A smaller subset of six of these O serogroups
was similarly evaluated in raw cow’s milk. For comparison,
portions of each of the 168 enrichment cultures were
analyzed by both real-time PCR and the Luminex
microsphere–based suspension array on the Bio-Plex 200
instrument. Through the use of a dual laser system, the Bio-
Plex 200 system can measure and quantitate fluorescence
signals for each microsphere detected and can categorize the
microsphere by region. Data are expressed as median
fluorescent intensities for each microsphere region. For each
sample, a signal-to-background ratio is calculated by
dividing the median fluorescent intensity for a particular
bead region by the corresponding intensity generated by a
no-template control sample. Based on the assay validation,
when this ratio exceeds 5.0, the sample is considered
positive for that serogroup (11, 12).
Real-time PCR analysis was conducted once for each
serotype and food commodity following instructions in
Section O of Chapter 4a in the BAM (6). Table 1 provides
results of both the real-time PCR and Bio-Plex assays for all
E. coli strains tested in the four food matrices. For the real-
time PCR assay, cycle threshold (C
T
) values are reported
and are compared with the ratios generated for the same
sample with the Bio-Plex 200 instrument. For the 168
samples analyzed, no false-positive results were obtained,
i.e., a sample negative for E. coli with the real-time PCR
assay was also negative with the Bio-Plex assay. Results for
the O128 serogroup are not shown in Table 1 because no
positive enrichment samples were obtained for any test
portions by real-time PCR or the Bio-Plex assay. Consul-
tation with the provider revealed that this particular O128
strain does not possess either of the Shiga toxin genes (stx
1
or stx
2
) detected by the BAM real-time PCR method,
making it difficult to compare results with those of the Bio-
1624 KASE ET AL. J. Food Prot., Vol. 79, No. 9
Downloaded from http://meridian.allenpress.com/jfp/article-pdf/79/9/1623/2322935/0362-028x_jfp-16-070.pdf by guest on 02 January 2023
TABLE 1. Results of analysis of enrichment culture samples analyzed by both the Bio-Plex 200 instrument and real-time PCR
a
E. coli
serogroup Trial
Baby spinach Cilantro Alfalfa sprouts Raw milk
b
Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
)
O26 1 ,5.0 Pos (27.03 stx
1
),5.0 ND Pos Pos (26.80 stx
1
),5.0 Pos (39.21 stx
1
)
Pos
c
,5.0
c
Pos
d
,5.0
d
2,5.0 ND ,5.0 Pos (39.07 stx
1
) Pos Pos (34.35 stx
1
),5.0 Pos (35.64 stx
1
)
,5.0
c
Pos
c
,5.0
d
Pos
d
3,5.0 ND Pos Pos (24.49 stx
1
) Pos Pos (26.85 stx
1
),5.0 Pos (38.59 stx
1
)
,5.0
c
,5.0
d
4,5.0 ND ,5.0 Pos (39.20 stx
1
) Pos Pos (26.45 stx
1
),5.0 Pos (38.29 stx
1
)
,5.0
c
,5.0
c
,5.0
d
,5.0
d
O45 1 ,5.0 ND Pos Pos (24.25 stx
1
),5.0 ND ,5.0 ND
2 Pos Pos (24.59 stx
1
),5.0 Pos (37.75 stx
1
),5.0 ND ,5.0 ND
Pos
c
Pos
d
3 Pos Pos (23.54 stx
1
),5.0 ND ,5.0 ND ,5.0 ND
4 Pos Pos (24.08 stx
1
) Pos Pos (24.99 stx
1
),5.0 ND ,5.0 ND
O91 1 Pos Pos (25.48 stx
1
),5.0 ND Pos Pos (30.76 stx
1
)
2 Pos Pos (26.15 stx
1
) Pos Pos (26.50 stx
1
) Pos Pos (31.36 stx
1
)
3 Pos Pos (26.87 stx
1
),5.0 ND ,5.0 ND
4 Pos Pos (29.34 stx
1
) Pos Pos (26.09 stx
1
) Pos Pos (32.31 stx
1
)
O103 1 Pos Pos (23.09 stx
1
) Pos Pos (23.10 stx
1
),5.0 ND Pos Pos (30.08 stx
1
)
2,5.0 ND Pos Pos (22.40 stx
1
) Pos Pos (26.76 stx
1
) Pos Pos (29.52 stx
1
)
3 Pos Pos (23.28 stx
1
) Pos Pos (22.69 stx
1
) Pos Pos (25.50 stx
1
) Pos Pos (30.36 stx
1
)
4,5.0 ND ,5.0 ND Pos Pos (25.01 stx
1
) Pos Pos (30.71 stx
1
)
O104:H4 1 Pos Pos (25.86 stx
2
) Pos Pos (27.81 stx
2
) Pos Pos (31.25 stx
2
)
2,5.0 Pos (35.57 stx
2
) Pos Pos (30.26 stx
2
) Pos Pos (33.31 stx
2
)
Pos
c
Pos
d
3 Pos Pos (27.14 stx
2
) Pos Pos (29.20 stx
2
) Pos Pos (33.46 stx
2
)
4 Pos Pos (26.07 stx
2
) Pos Pos (28.41 stx
2
) Pos Pos (32.04 stx
2
)
O104:H21 1 ,5.0 Pos (36.63 stx
2
) Pos Pos (27.08 stx
2
),5.0 Pos (38.33 stx
2
),5.0 Pos (35.36 stx
2
)
Pos
c
Pos
c
Pos
c
Pos
d
Pos
d
Pos
d
2,5.0 Pos (36.12 stx
2
) Pos Pos (26.80 stx
2
),5.0 Pos (35.09 stx
2
),5.0 ND
Pos
c
Pos
c
Pos
d
Pos
d
J. Food Prot., Vol. 79, No. 9 E. COLI O SEROGROUP IDENTIFICATION FROM FOOD ENRICHMENTS 1625
Downloaded from http://meridian.allenpress.com/jfp/article-pdf/79/9/1623/2322935/0362-028x_jfp-16-070.pdf by guest on 02 January 2023
TABLE 1. Continued
E. coli
serogroup Trial
Baby spinach Cilantro Alfalfa sprouts Raw milk
b
Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
)
O104:H21
(cont’d)
3 Pos Pos (23.98 stx
2
) Pos Pos (35.10 stx
2
),5.0 Pos (36.82 stx
2
) Pos Pos (36.05 stx
2
)
Pos
c
Pos
d
4 Pos Pos (26.22 stx
2
) Pos Pos (33.93 stx
2
),5.0 Pos (36.63 stx
2
) Pos Pos (32.04 stx
2
)
Pos
c
Pos
d
O111 1 ,5.0 ND ,5.0 ND ,5.0 ND ,5.0 Pos (37.62 stx
1
; 39.05 stx
2
)
,5.0
c
,5.0
d
2,5.0 ND ,5.0 Pos (35.47 stx
1
; 37.96 stx
2
),5.0 Pos (39.24 stx
1
; 36.60 stx
2
),5.0 Pos (39.44 stx
1
; 38.75 stx
2
)
,5.0
c
,5.0
c
,5.0
c
Pos
d
(7.13) ,5.0
d
,5.0
d
3,5.0 ND ,5.0 Pos (35.24 stx
1
; 37.54 stx
2
),5.0 Pos (stx
1
ND; 38.64 stx
2
),5.0 ND
,5.0
c
Pos
c
Pos
d
(7.37) Pos
d
4,5.0 ND ,5.0 Pos (37.15 stx
1
; 38.99 stx
2
),5.0 Pos (stx
1
ND; 38.52 stx
2
),5.0 Pos (36.62 stx
1
; 36.64 stx
2
)
,5.0
c
,5.0
c
,5.0
c
,5.0
d
,5.0
d
,5.0
d
O113 1 ,5.0 ND ,5.0 ND ,5.0 Pos (37.94 stx
2
)
Pos
c
Pos
d
2 Pos Pos (28.50 stx
2
) Pos Pos (29.25 stx
2
),5.0 Pos (39.26 stx
2
)
Pos
c
Pos
d
3 Pos Pos (28.62 stx
2
),5.0 ND ,5.0 Pos (36.11 stx
2
)
Pos
c
Pos
d
4,5.0 ND Pos Pos (29.36 stx
2
),5.0 ND
O121 1 ,5.0 ND Pos Pos (25.22 stx
2
),5.0 ND
2 Pos Pos (23.53 stx
2
) Pos Pos (26.19 stx
2
),5.0 Pos (39.78 stx
2
)
Pos
c
Pos
d
3 Pos Pos (24.09 stx
2
),5.0 ND ,5.0 Pos (36.24 stx
2
)
Pos
c
Pos
d
4,5.0 ND ,5.0 ND ,5.0 Pos (38.51 stx
2
)
Pos
c
Pos
d
1626 KASE ET AL. J. Food Prot., Vol. 79, No. 9
Downloaded from http://meridian.allenpress.com/jfp/article-pdf/79/9/1623/2322935/0362-028x_jfp-16-070.pdf by guest on 02 January 2023
TABLE 1. Continued
E. coli
serogroup Trial
Baby spinach Cilantro Alfalfa sprouts Raw milk
b
Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
) Bio-Plex PCR (C
T
)
O145 1 ,5.0 Pos (38.66 stx
1
) Pos Pos (22.33 stx
1
),5.0 ND ,5.0 ND
Pos
c
Pos
d
2 Pos Pos (21.78 stx
1
),5.0 ND ,5.0 ND ,5.0 Pos (34.59 stx
1
)
Pos
c
Pos
d
3 Pos Pos (21.35 stx
1
) Pos Pos (33.60 stx
1
),5.0 ND ,5.0 Pos (37.19 stx
1
)
Pos
c
Pos
d
4 Pos Pos (21.32 stx
1
) Pos Pos (22.96 stx
1
) Pos Pos (21.13 stx
1
),5.0 Pos (37.12 stx
1
)
Pos
c
Pos
d
O157:H7 1 ,5.0 Pos (38.90 stx
1
; 37.33 stx
2
) Pos Pos (32.60 stx
1
; 31.33 stx
2
),5.0 Pos (38.45 stx
1
;stx
2
ND)
Pos
c
,5.0
c
Pos
d
Pos (20.1)
d
2 Pos Pos (26.99 stx
1
; 25.29 stx
2
) Pos Pos (32.53 stx
1
; 31.37 stx
2
),5.0 Pos (stx
1
ND; 37.78 stx
2
)
Pos
c
Pos
d
3 Pos Pos (25.12 stx
1
; 23.50 stx
2
) Pos Pos (32.97 stx
1
; 31.42 stx
2
),5.0 Pos (stx
1
ND; 38.81 stx
2
)
Pos
c
Pos
d
4,5.0 Pos (stx
1
ND; 37.89 stx
2
) Pos Pos (34.67 stx
1
; 32.41 stx
2
),5.0 Pos (38.27 stx
1
; 37.55 stx
2
)
Pos
c
Pos
c
Pos
d
Pos
d
a
Signal-to-background ratios are reported for the Bio-Plex assay, and C
T
values are given for the real-time PCR assay. The resulting PCR product for each enrichment culture sample was run in
triplicate on the Bio-Plex 200 instrument, and mean ratios are reported. Bold results indicate a possible limit of detection for the Bio-Plex 200 assay when testing fresh produce food enrichment
cultures. When a test portion produced a C
T
value but did not generate a Bio-Plex ratio above 5.0, the undiluted and extracted enrichment material was tested. Results for O128 serogroup are not
shown because no positive results were obtained for any enrichment culture test portions. ND, not detected (no C
T
value generated).
b
Not all E. coli serogroups were evaluated in raw milk.
c
Result for undiluted enrichment culture.
d
Result for extracted enrichment culture.
J. Food Prot., Vol. 79, No. 9 E. COLI O SEROGROUP IDENTIFICATION FROM FOOD ENRICHMENTS 1627
Downloaded from http://meridian.allenpress.com/jfp/article-pdf/79/9/1623/2322935/0362-028x_jfp-16-070.pdf by guest on 02 January 2023
Plex assay. All uninoculated (control) portions processed
with the corresponding inoculated samples were negative
with both assays (data not shown). All positive and negative
(no template) controls run with these samples also
performed as expected. Of the 112 diluted samples with a
reported C
T
value, 71 also produced ratios above 5.0 in the
Bio-Plex assay (Table 1). A closer look at those diluted test
portions that produced a negative result in the Bio-Plex
assay (shown in bold in Table 1) revealed that the
corresponding C
T
values were close to or greater than 35.
This was true for 41 test portions across all four types of
food, with three notable exceptions: baby spinach O26 trial
1, cilantro O104:H21 trial 3, and raw milk O104:H21 trial 3.
For the diluted cilantro enrichment, a strong ratio of 19.58
was obtained for the Bio-Plex assay, and the corresponding
real-time PCR C
T
was 35.10. However, in the raw milk trial,
the Bio-Plex ratio was 5.34, close to the 5.0 cutoff for a
positive result and the C
T
was higher, 36.05. For baby
spinach O26 trail 1, the C
T
was 27.03, but the parallel Bio-
Plex assay result was below 5.0. However, use of both the
undiluted and extracted enrichment material produced a
positive Bio-Plex result. These three findings suggest that a
real-time PCR C
T
of 35 might not be an absolute breaking
point in terms of obtaining a positive Bio-Plex assay result.
When a test portion produced a C
T
value but did not
generate a Bio-Plex ratio above 5.0, the undiluted and
extracted enrichment material was tested (Table 1). Overall,
this additional testing resulted in a significant increase (P,
0.0001) in positive test portions for undiluted (increase of
27) or extracted (increase of 30) material. DNA extraction
resulted in positive samples for O111 cilantro trials 2 and 3
and O157:H7 alfalfa sprouts trial 1. However, the Bio-Plex
ratios for the cilantro trials were very close to the cutoff of
5.0 (7.1 and 7.4, respectively). For O157:H7 alfalfa sprouts
trial 1, the resulting ratio was 20.1.
DISCUSSION
The current BAM (6) describes characterization of
STEC isolates by detecting virulence factors (e.g., stx
1
or
stx
2
) and identifying the most clinically relevant O
serogroups using a Luminex microsphere–based suspension
array. The array can identify the 11 most clinically relevant
STEC serogroups (O26, O45, O91, O103, O104, O111,
O113, O121, O128, O145, and O157) and is performed in
96-well plates, allowing for high-throughput screening for a
large number of analytes. Previous studies have demon-
strated that the assay is reproducible (giving positive results
more than two standard deviations above the threshold
value), accurate (identifying 114 STECs correctly with no
false-positive results among 46 negative control isolates),
and robust (correctly identifying STECs with 96.4 to 100%
accuracy in a blinded collaborative study involving 55
unknown strains and nine laboratories) (11, 12).The
Luminex array also is adaptable, producing accurate results
on both the Bio-Plex 200 and MAGPIX systems with only
minor adjustments.
Because this assay has demonstrated its usefulness for
confirming certain STEC colonies, we decided to evaluate
its use with early positive enrichment samples before
incubation on agar plates. This adaptation requires no
additional effort or modification because the same enrich-
ment aliquot is prepared for real-time PCR analysis and the
same Bio-Plex reagents and procedures currently outlined in
the BAM can be used. Often the process of screening
colonies from multiple agars is laborious and expensive for
samples ultimately deemed negative for pathogenic E. coli.
Worse is the potential to miss positive colonies because only
subsets of colonies with typical characteristics are screened.
Initial screening of enrichment cultures for the presence of
certain pathogenic STEC would provide early and valuable
indication of a positive sample, which could result in a more
focused effort to obtain a colony isolate and possibly quicker
intervention to protect public health. For example, in a
previous study the agars recommended in the BAM varied in
performance depending on the E. coli O serogroup tested
(9). The enrichment culture screening method detailed here
would provide an early indication of the presence of certain
E. coli serogroups, and selection of a high-performance agar
would be possible based on results from the screening.
Screening would also provide information about typical
colony appearance for the agars evaluated, thus allowing
better use of limited colony picks. More aggressive attempts
might be made to obtain a positive colony from a food
sample culture with an early indication of a clinically
relevant E. coli strain.
This Luminex assay can be extended to effectively
screen food enrichment samples in addition to bacterial
colonies. However, care should be taken with regard to
negative Bio-Plex results. We verified that the sensitivity of
the conventional PCR step is less than that of the equivalent
real-time PCR analysis as indicated by Bio-Plex ratios below
5.0 when C
T
values approach 35. This limitation was
expected because generally smaller amounts of DNA are
detectable with the real-time PCR assay. For this study, we
attempted to obtain a mix of positive and negative results for
thorough assay evaluation and subsequently obtained C
T
values close to the maximum of 40. For 41 samples a C
T
value was recorded in the absence of a positive Bio-Plex
assay result (Table 1); therefore, a Bio-Plex ratio of less than
5.0 does not always mean that the sample does not contain
an STEC belonging to one of the 11 serogroups that are part
of the Bio-Plex assay. However, in a natural contamination
event and with subsequent robust food enrichment, the Bio-
Plex assay should be able to detect a positive sample,
because more DNA template should be present. Analysis of
undiluted enrichment cultures resulted in a 24% increase in
the number of positive samples. However, as with any
molecular assay, positive signals can be generated from both
live and dead bacterial cells.
In summary, with no modification to the current Bio-
Plex assay method detailed in Chapter 4a of the BAM and
using the same enrichment material prepared for real-time
PCR analysis, the STEC microbead-based suspension array
can be used to accurately screen food enrichments for the 11
O serogroups validated for the current assay. Thus, we
recommend the expanded use of this assay as a rapid first
screen of undiluted E. coli food enrichment cultures to
provide an early indication of contamination with potentially
pathogenic STEC. Rapid and high-throughput identification
and serotyping of STEC O serogroups is important for
1628 KASE ET AL. J. Food Prot., Vol. 79, No. 9
Downloaded from http://meridian.allenpress.com/jfp/article-pdf/79/9/1623/2322935/0362-028x_jfp-16-070.pdf by guest on 02 January 2023
detecting, investigating, and controlling STEC infection
outbreaks and removing hazardous products from com-
merce.
ACKNOWLEDGMENT
This project was supported in part by an appointment (A.
Maounounen-Laasri) to the Research Participation Program at the Center
for Food Safety and Applied Nutrition administered by the Oak Ridge
Institute for Science and Education.
REFERENCES
1. Bettelheim, K. A. 2007. The non-O157 Shiga-toxigenic (verocyto-
toxigenic) Escherichia coli; under-rated pathogens. Crit. Rev. Micro-
biol. 33:67–87.
2. Beutin, L., and A. Martin. 2012. Outbreak of Shiga toxin–producing
Escherichia coli (STEC) O104:H4 infection in Germany causes a
paradigm shift with regard to human pathogenicity of STEC strains. J.
Food Prot. 75:408–418.
3. Brooks, J. T., E. G. Sowers, J. G. Wells, K. D. Greene, P. M. Griffin,
R. M. Hoekstra, and N. A. Strockbine. 2005. Non-O157 Shiga toxin–
producing Escherichia coli infections in the United States, 1983–
2002. J. Infect. Dis. 192:1422–1429.
4. Caprioli, A., S. Morabito, H. Brug`
ere, and E. Oswald. 2005.
Enterohaemorrhagic Escherichia coli: emerging issues on virulence
and modes of transmission. Vet. Res. 36:289–311.
5. Erickson, M. C., and M. P. Doyle. 2007. Food as a vehicle for
transmission of Shiga toxin–producing Escherichia coli.J. Food Prot.
70:2426–2449.
6. Feng, P., S. D. Weagant, and K. Jinneman. 2013. Diarrheagenic
Escherichia coli, chap. 4a. In Bacteriological analytical manual.
Available at: http://www.fda.gov/Food/FoodScienceResearch/
LaboratoryMethods/ucm070080.htm. Accessed ??
7. Gyles, C. L. 2007. Shiga toxin–producing Escherichia coli:an
overview. J. Anim. Sci. 85:E45–E62.
8. Johnson, K. E., C. M. Thorpe, and C. L. Sears. 2006. The emerging
clinical importance of non-O157 Shiga toxin–producing Escherichia
coli.Clin. Infect. Dis. 43:1587–1595.
9. Kase, J. A., A. Maounounen-Laasri, I. Son, A. Lin, and T. S.
Hammack. 2015. Comparison of eight different agars for the recovery
of clinically relevant non-O157 Shiga toxin–producing Escherichia
coli from baby spinach, cilantro, alfalfa sprouts and raw milk. Food
Microbiol. 46:280–287.
10. Levine, M. M., J.-G. Xu, J. B. Kaper, H. Lior, V. Prado, B. Tall, J.
Nataro, H. Karch, and K. Wachsmuth. 1987. A DNA probe to identify
enterohemorrhagic Escherichia coli of O157:H7 and other serotypes
that cause hemorrhagic colitis and hemolytic uremic syndrome. J.
Infect. Dis. 156:175–182.
11. Lin, A., J. A. Kase, M. M. Moore, I. Son, N. Tran, L. M. Clotilde, K.
Jarvis, K. Jones, K. Kasturi, K. Nabe, M. Nucci, G. S. Wagley, F.
Wang, B. Ge, and T. S. Hammack. 2013. Multilaboratory validation
of a Luminex microbead-based suspension array for the identification
of the 11 most clinically relevant Shiga toxin–producing Escherichia
coli O serogroups. J. Food Prot. 76:867–870.
12. Lin, A., L. Nguyen, T. Lee, L. M. Clotilde, J. A. Kase, I. Son, J. M.
Carter, and C. R. Lauzon. 2011. Rapid O serogroup identification of
the ten most clinically relevant STECs by Luminex microbead-based
suspension array. J. Microbiol. Methods 87:105–110.
13. Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of
Shiga toxin–producing Escherichia coli infections. Clin. Microbiol.
Rev. 11:450–479.
14. Scallan, E., R. M. Hoekstra, F. J. Angulo, R. V. Tauxe, M. A.
Widdowson, S. L. Roy, J. L. Jones, and P. M. Griffin. 2011.
Foodborne illness acquired in the United States—major pathogens.
Emerg. Infect. Dis. 17:7–15.
15. Tauxe, R., H. Kruse, C. Hedberg, M. Potter, J. Madden, and K.
Wachsmuth. 1997. Microbial hazards and emerging issues associated
with produce. A preliminary report to the National Advisory
Committee on Microbiologic Criteria for Foods. J. Food Prot.
60:1400–1408.
16. World Health Organization. 2011. EHEC outbreak: increased cases in
Germany. World Health Organization, Geneva. Available at: http://
www.euro.who.int/en/health-topics/emergencies/international-health-
regulations/outbreaks-of-e.-coli-o104h4-infection. Accessed 12 June
2016
J. Food Prot., Vol. 79, No. 9 E. COLI O SEROGROUP IDENTIFICATION FROM FOOD ENRICHMENTS 1629
Downloaded from http://meridian.allenpress.com/jfp/article-pdf/79/9/1623/2322935/0362-028x_jfp-16-070.pdf by guest on 02 January 2023
... SAT's complete liquid-phase reaction system, which is close to the internal environment of biological systems, is gaining momentum in the biological and pharmaceutical fields [20]. It gradually becomes a powerful tool for food sample analysis [21][22][23], which is capable to rapidly and accurately analyze most contaminants in food, including pesticides and veterinary drugs, hormones, antibiotics, biotoxins, and illegal additives [24][25][26][27]. Technological advances have enabled the transition of commercialized small molecule antibodies from multi-antibodies to monoclonal antibodies, and the price has decreased substantially [28]. ...
Article
Full-text available
A low cost and effective indirect competitive method is reported to detect five EDCs, 17-beta-estradiol (E2), estriol (E3), bisphenol A (BPA), diethylstilbestrol (DES), and nonylphenol (NP) simultaneously, based on suspension array technology (SAT). Five kinds of complete antigens (E2-BSA, E3-BSA, BPA-BSA, DES-BPA, NP-BSA) were coupled to different encoding microspheres using purpose-made solutions in our laboratory instead of commercially available amino coupling kits; the method was further optimized for determination and reducing the cost. Encoding and signaling fluorescence of the particles are determined at 635/532 nm emission wavelengths. High-throughput curves of five EDCs were draw and the limit of detection (LOD) were between 0.0010 ng mL⁻¹ ~ 0.0070 ng mL⁻¹. Compared with traditional ELISA methods, the SAT exhibited better specificity and sensitivity. Experiments using spiked milk and tap water samples were also carried out, and the recovery was between 85 and 110%; the results also confirmed good repeatability and reproducibility. It illustrated great potential of the present strategy in the detection of EDCs in actual samples. Graphical abstract
... Another area of future study is to evaluate the effectiveness of the suspension array in screening food, environmental, and clinical samples. A preliminary study of artificially inoculated fresh produce and raw milk resulted in over 90% agreement between the suspension array and qPCR screening for stx1 and/or stx2 genes (Kase et al., 2015). Further improvements such as including an internal amplification control would be useful especially when screening enrichments to ensure that PCR inhibition does not cause false negative results. ...
Article
Full-text available
Molecular methods have emerged as the most reliable techniques to detect and characterize pathogenic Escherichia coli. These molecular techniques include conventional single analyte and multiplex PCR, PCR followed by microarray detection, pulsed-field gel electrophoresis (PFGE), and whole genome sequencing. The choice of methods used depends upon the specific needs of the particular study. One versatile method involves detecting serogroup-specific markers by hybridization or binding to encoded microbeads in a suspension array. This molecular serotyping method has been developed and adopted for investigating E. coli outbreaks. The major advantages of this technique are the ability to simultaneously serotype E. coli and detect the presence of virulence and pathogenicity markers. Here, we describe the development of a family of multiplex molecular serotyping methods for Shiga toxin-producing E. coli (STEC), compare their performance to traditional serotyping methods, and discuss the cost-benefit balance of these methods in the context of various food safety objectives.
Article
Food safety is an important livelihood issue, which has always been focused attention by countries and governments all over the world. As food supply chains are becoming global, food quality control is essential for consumer protection as well as for the food industry. In recent years, a great part of food analysis is carried out using new techniques for rapid detection. As the first biochip technology that has been approved by the Food and Drug Administration (FDA), there is an increasing interest in suspension array technology (SAT) for food and environmental analysis with advantages of rapidity, high accuracy, sensitivity, and throughput. Therefore, it is important for researchers to understand the development and application of this technology in food industry. Herein, we summarized the principle and composition of SAT and its application in food safety monitoring. The utility of SAT in detection of foodborne microorganisms, residues of agricultural and veterinary drugs, genetically modified food and allergens in recent years is elaborated, and the further development direction of SAT is envisaged.
Article
Full-text available
Rapid and high-throughput identification and serotyping of Shiga toxin-producing Escherichia coli (STEC) O serogroups is important for detecting, investigating, and controlling STEC infection outbreaks and removing hazardous products from commerce. A Luminex microbead-based suspension array has been developed to identify the 11 most clinically relevant STEC serogroups: O26, O45, O91, O103, O104, O111, O113, O121, O128, O145, and O157. Here we present results of a blinded multilaboratory collaborative study involving 10 participants from nine laboratories using 55 unknown strains. From the total 495 analyses, two false-positive and three false-negative results were obtained, indicating the assay to be a rapid, high-throughput, and robust method for identifying clinically relevant STEC serogroups.
Article
Full-text available
In the past two decades, the consumption of fresh fruits and vegetables in the United States has increased, and the geographic sources and distribution of fresh produce have expanded greatly. Concomitantly, public health officials have documented an increase in the number of reported produce-associated foodborne disease outbreaks in the United States. The Centers for Disease Control and Prevention (CDC) reports that the number of these outbreaks doubled between 1973 and 1987, and 1988 and 1991, and that the number of cases of illness associated with these outbreaks more than doubled. A variety of produce items have been affected. During 1995 alone, major outbreak investigations linked infections with Salmonella serotype Stanley to alfalfa sprouts, Salmonella Hartford to unpasteurized orange juice, Shigella spp. to lettuce and green onions, Escherichia coli O157:H7 to lettuce, and hepatitis A virus to tomatoes. In response to this apparent increase, the U.S. Food and Drug Administration asked the National Advisory Committee on Microbiological Criteria for Foods to address and better define the association of foodborne disease and microbial pathogens with fresh produce. A subcommittee formed in June 1995 is documenting relevant epidemiologic data, current industry practices, and laboratory data to identify potential hazards and related control strategies. This report presents the preliminary findings of that subcommittee.
Article
Full-text available
An outbreak that comprised 3,842 cases of human infections with enteroaggregative hemorrhagic Escherichia coli (EAHEC) O104:H4 occurred in Germany in May 2011. The high proportion of adults affected in this outbreak and the unusually high number of patients that developed hemolytic uremic syndrome makes this outbreak the most dramatic since enterohemorrhagic E. coli (EHEC) strains were first identified as agents of human disease. The characteristics of the outbreak strain, the way it spread among humans, and the clinical signs resulting from EAHEC infections have changed the way Shiga toxin-producing E. coli strains are regarded as human pathogens in general. EAHEC O104:H4 is an emerging E. coli pathotype that is endemic in Central Africa and has spread to Europe and Asia. EAHEC strains have evolved from enteroaggregative E. coli by uptake of a Shiga toxin 2a (Stx2a)-encoding bacteriophage. Except for Stx2a, no other EHEC-specific virulence markers including the locus of enterocyte effacement are present in EAHEC strains. EAHEC O104:H4 colonizes humans through aggregative adherence fimbrial pili encoded by the enteroaggregative E. coli plasmid. The aggregative adherence fimbrial colonization mechanism substitutes for the locus of enterocyte effacement functions for bacterial adherence and delivery of Stx2a into the human intestine, resulting clinically in hemolytic uremic syndrome. Humans are the only known natural reservoir known for EAHEC. In contrast, Shiga toxin-producing E. coli and EHEC are associated with animals as natural hosts. Contaminated sprouted fenugreek seeds were suspected as the primary vehicle of transmission of the EAHEC O104:H4 outbreak strain in Germany. During the outbreak, secondary transmission (human to human and human to food) was important. Epidemiological investigations revealed fenugreek seeds as the source of entry of EAHEC O104:H4 into the food chain; however, microbiological analysis of seeds for this pathogen produced negative results. The survival of EAHEC in seeds and the frequency of human carriers of EAHEC should be investigated for a better understanding of EAHEC transmission routes.
Article
Full-text available
Identification and serotyping of Shiga toxin-producing Escherichia coli during foodborne outbreaks can aid in matching clinical, food, and environmental isolates when trying to identify the source of illness and ultimately food contamination. Herein we describe a Luminex microbead-based suspension array to identify the O serogroup of the ten most clinically relevant STECs: O26, O45, O91, O103, O111, O113, O121, O128, O145, and O157. The use of PCR followed by Luminex xMAP® technology enables the detection of multiple analytes in a single multiplex reaction with high throughput capabilities. One hundred and fourteen STEC isolates were correctly identified with no false positives among forty-six other organisms using this assay. Assay performance was tested in multiple laboratories using a panel of eleven different STEC serogroups on the Bio-Plex 200 and MAGPIX instruments. The STEC microbead-based suspension array can be performed in a 96-well plate format for high throughput screening in less than 4h. Furthermore, it is expandable, allowing for the addition of O serogroups should the need arise.
Article
Full-text available
Estimates of foodborne illness can be used to direct food safety policy and interventions. We used data from active and passive surveillance and other sources to estimate that each year 31 major pathogens acquired in the United States caused 9.4 million episodes of foodborne illness (90% credible interval [CrI] 6.6–12.7 million), 55,961 hospitalizations (90% CrI 39,534–75,741), and 1,351 deaths (90% CrI 712–2,268). Most (58%) illnesses were caused by norovirus, followed by nontyphoidal Salmonella spp. (11%), Clostridium perfringens (10%), and Campylobacter spp. (9%). Leading causes of hospitalization were nontyphoidal Salmonella spp. (35%), norovirus (26%), Campylobacter spp. (15%), and Toxoplasma gondii (8%). Leading causes of death were nontyphoidal Salmonella spp. (28%), T. gondii (24%), Listeria monocytogenes (19%), and norovirus (11%). These estimates cannot be compared with prior (1999) estimates to assess trends because different methods were used. Additional data and more refined methods can improve future estimates.
Article
Full-text available
Enterohemorrhagic Escherichia coli (EHEC) cause hemorrhagic colitis and hemolytic uremic syndrome (HUS), make potent cytotoxins (Verotoxins [VT] or Shiga-like toxins), and possess a plasmid (∼60 megadaltons) that encodes a new fimbrial antigen and promotes attachment to epithelial cells.Weevaluated the use of a DNA probe, prepared from a 3.4-kilobase segment of the EHEC plasmid, to detect EHEC. The probe hybridized with 106 (99%) of 107 O157:H7 and 34 (77%) of 44 O26:H11, VT-positive strains from patients with colitis, HUS, and diarrheal disease and hybridized with 21 (81%) of 26 VT-positive E. coli of serotypes other than O157:H7 or O26:H11 from patients with hemorrhagic colitis and HUS. Weexamined 601 other strains, including 18 serotype O26 isolates of H types other than H11, 306 enteropathogenic E. coli, 60 enteroinvasive E. coli, 119 enterotoxigenic E. coli, and 20 isolates from the urinary tract and 77 isolates from the normal intestinal flora; only one (O127:H-) was positive (specificity, 99.8%). Serotype O26:H11, previously considered a classic enteropathogenic E. coli serotype, is now shown to be EHEC.
Article
Full-text available
Since their initial recognition 20 years ago, Shiga toxin-producing Escherichia coli (STEC) strains have emerged as an important cause of serious human gastrointestinal disease, which may result in life-threatening complications such as hemolytic-uremic syndrome. Food-borne outbreaks of STEC disease appear to be increasing and, when mass-produced and mass-distributed foods are concerned, can involve large numbers of people. Development of therapeutic and preventative strategies to combat STEC disease requires a thorough understanding of the mechanisms by which STEC organisms colonize the human intestinal tract and cause local and systemic pathological changes. While our knowledge remains incomplete, recent studies have improved our understanding of these processes, particularly the complex interaction between Shiga toxins and host cells, which is central to the pathogenesis of STEC disease. In addition, several putative accessory virulence factors have been identified and partly characterized. The capacity to limit the scale and severity of STEC disease is also dependent upon rapid and sensitive diagnostic procedures for analysis of human samples and suspect vehicles. The increased application of advanced molecular technologies in clinical laboratories has significantly improved our capacity to diagnose STEC infection early in the course of disease and to detect low levels of environmental contamination. This, in turn, has created a potential window of opportunity for future therapeutic intervention.
Article
Full-text available
Enterohaemorrhagic Escherichia coli (EHEC) constitute a subset of serotypes (E. coli O157 and some other serogroups) of Shiga toxin (Stx)-producing E. coli (STEC) firmly associated with severe human illnesses like bloody diarrhoea and haemolytic uraemic syndrome. Stx production is essential but not sufficient for EHEC virulence. Most strains are capable of colonising the intestinal mucosa of the host with the "attaching and effacing" mechanism, genetically governed by a large pathogenicity island (PAI) defined as the Locus of Enterocyte Effacement. Other virulence factors carried by mobile genetic elements like PAI and plasmids have been recently described, and their role in the pathogenic process has not been fully elucidated. EHEC are zoonotic pathogens. They rarely cause disease in animals, and ruminants are recognised as their main natural reservoir. Cattle are considered to be the most important source of human infections with EHEC O157, and the ecology of the organism in cattle farming has been extensively studied. The organism has also been reported in sheep, goats, water buffalos, and deer. Pigs and poultry are not considered to be a source of EHEC and the sporadic reports may derive from accidental exposure to ruminant dejections. The epidemiology of EHEC infections has remarkably changed during the past ten years and an increasing number of unusual food vehicles have been associated with human infections. New routes of transmission have emerged, like contact with animals during farm visits and a wide variety of environment-related exposures. As for other zoonotic agents, having animals and raw products that are free from EHEC is not possible in practice. However, their occurrence can be minimised by applying high standards of hygiene in all the steps of the food production chain.